Guttman-McCabe Christopher bought ATEX

August 25, 2026 · Form 4 insider transaction

Guttman-McCabe Christopher bought 40,000 shares of Anterix Inc. at $34.72 per share, a transaction worth $1.39M. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.